Literature DB >> 3884709

Chemotactic responses of human peripheral blood monocytes to the complement-derived peptides C5a and C5a des Arg.

S R Marder, D E Chenoweth, I M Goldstein, H D Perez.   

Abstract

We examined responses of human peripheral blood polymorphonuclear leukocytes (PMN) and monocytes to the highly purified human complement-derived peptides C5a and C5a des Arg. As reported previously, C5a proved to be approximately 10- to 20-fold more potent than C5a des Arg as a chemoattractant for human PMN. C5a also was more potent than C5a des Arg in causing PMN to acquire a polarized morphology. In contrast, we found that human monocytes do not distinguish between C5a and C5a des Arg when these peptides are used as chemoattractants. In two different assay systems, both peptides acted at identical concentrations to stimulate suboptimal and optimal migration of monocytes. Human monocytes also did not distinguish between C5a and C5a des Arg when these peptides were used as inducers of polarization. Studies performed with functionally active, [125I]-labeled C5a and C5a des Arg, however, demonstrated that binding of C5a des Arg to monocytes differed from binding of C5a. Although [125I]-C5a des Arg appeared to bind to the same receptor as [125I]-C5a, binding of labeled C5a des Arg occurred with an affinity that was approximately 100-fold less than that observed with labeled C5a. These results indicate that leukocyte chemotactic and polarization responses to C5a and C5a des Arg vary, depending on the target cell type.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3884709

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  48 in total

1.  Protein-mediated macrophage adhesion and activation on biomaterials: a model for modulating cell behavior.

Authors:  W J Kao; J A Hubbell; J M Anderson
Journal:  J Mater Sci Mater Med       Date:  1999 Oct-Nov       Impact factor: 3.896

Review 2.  Complement activation in the context of stem cells and tissue repair.

Authors:  Ingrid U Schraufstatter; Sophia K Khaldoyanidi; Richard G DiScipio
Journal:  World J Stem Cells       Date:  2015-09-26       Impact factor: 5.326

3.  Identification of receptor-binding residues in the inflammatory complement protein C5a by site-directed mutagenesis.

Authors:  K W Mollison; W Mandecki; E R Zuiderweg; L Fayer; T A Fey; R A Krause; R G Conway; L Miller; R P Edalji; M A Shallcross
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

Review 4.  Myelin as an inflammatory mediator: Myelin interactions with complement, macrophages, and microglia in spinal cord injury.

Authors:  Timothy J Kopper; John C Gensel
Journal:  J Neurosci Res       Date:  2017-07-11       Impact factor: 4.164

5.  Effects of fibrinogen derivatives upon the inflammatory response. Studies with human fibrinopeptide B.

Authors:  R M Senior; W F Skogen; G L Griffin; G D Wilner
Journal:  J Clin Invest       Date:  1986-03       Impact factor: 14.808

6.  The chemoattractant des-Arg74-C5a regulates the expression of its own receptor on a monocyte-like cell line.

Authors:  M D Barker; P J Jose; T J Williams; D R Burton
Journal:  Biochem J       Date:  1986-06-01       Impact factor: 3.857

7.  Increased soluble p55 and p75 tumour necrosis factor-alpha receptors in patients with hepatitis C-associated mixed cryoglobulinaemia.

Authors:  G Kaplanski; V Marin; T Maisonobe; A Sbai; C Farnarier; P Ghillani; X Thirion; J M Durand; J R Harlé; P Bongrand; J C Piette; P Cacoub
Journal:  Clin Exp Immunol       Date:  2002-01       Impact factor: 4.330

8.  C5a receptor mediates neutrophil activation and ANCA-induced glomerulonephritis.

Authors:  Adrian Schreiber; Hong Xiao; J Charles Jennette; Wolfgang Schneider; Friedrich C Luft; Ralph Kettritz
Journal:  J Am Soc Nephrol       Date:  2008-12-10       Impact factor: 10.121

Review 9.  Anaphylatoxins: their role in bacterial infection and inflammation.

Authors:  Pieter-Jan Haas; Jos van Strijp
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

Review 10.  Immunoglobulin G: a potential treatment to attenuate neuroinflammation following spinal cord injury.

Authors:  Michael G Fehlings; Dung H Nguyen
Journal:  J Clin Immunol       Date:  2010-05       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.